84.70

0.31% 0.26

Crinetics Pharmaceuticals Inc (CRNX)

Overview News Price History Option Chain Financials Why CRNX Down? Discussions Forecast

Crinetics Pharmaceuticals Inc stock is traded at $84.70, with a volume of 2.28M. It is up +0.31% in the last 24 hours and up +1.18% over the past month. Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Previous Close:

$84.44

Open:

$84.38

24h Volume:

2.28M

Relative Volume:

0.63

Market Cap:

$8.99B

Revenue:

$18.07M

Net Income/Loss:

$-496.39M

P/E Ratio:

-16.50

EPS:

-5.1333

Net Cash Flow:

$-419.52M

1W Performance:

+0.74%

1M Performance:

+1.18%

6M Performance:

+98.36%

1Y Performance:

+185.28%

1-Day Range:

$84.36

$84.70

1-Week Range:

$83.96

$84.71

52-Week Range:

$28.73

$84.71

Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile

Name

Crinetics Pharmaceuticals Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

858-450-6464

Address

6055 LUSK BLVD., SAN DIEGO, CA

Employee

594

Twitter

@Crinetics

Next Earnings Date

2026-08-04

Latest SEC Filings

CRNX's Discussions on Twitter

Compare CRNX vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRNX Crinetics Pharmaceuticals Inc	84.70	8.96B	18.07M	-496.39M	-419.52M	-5.1333
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-12-26	Upgrade	Goldman	Neutral → Buy
Jul-10-25	Initiated	Goldman	Neutral
Mar-25-25	Initiated	Stifel	Buy
Feb-11-25	Initiated	TD Cowen	Buy
Feb-04-25	Initiated	Wolfe Research	Peer Perform
Jan-22-25	Upgrade	Jefferies	Hold → Buy
Mar-06-24	Initiated	Citigroup	Buy
Jan-16-24	Initiated	Morgan Stanley	Overweight
Dec-21-23	Initiated	Jefferies	Hold
Nov-20-23	Resumed	JP Morgan	Overweight
Oct-24-23	Resumed	Cantor Fitzgerald	Overweight
Aug-31-23	Initiated	Oppenheimer	Outperform
Apr-24-23	Initiated	Piper Sandler	Overweight
Mar-30-23	Initiated	Robert W. Baird	Outperform
Nov-30-21	Initiated	JMP Securities	Mkt Outperform
Nov-23-21	Initiated	Evercore ISI	Outperform
Jun-18-21	Upgrade	JP Morgan	Neutral → Overweight
Dec-23-19	Initiated	ROTH Capital	Buy
Feb-14-19	Initiated	H.C. Wainwright	Buy
Aug-13-18	Initiated	JP Morgan	Neutral
Aug-13-18	Initiated	Leerink Partners	Outperform
Aug-13-18	Initiated	Piper Jaffray	Overweight

View All

Crinetics Pharmaceuticals Inc Stock (CRNX) Latest News

Aug 14, 2026

Vertex-Crinetics pharma merger cleared in US, Germany, Austria, Australia - MLex

Aug 14, 2026

Crinetics Pharmaceuticals merger with Vertex Pharmaceuticals advances after regulatory clearances - Investing.com

Aug 14, 2026

Form 8K Crinetics Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com Canada

Aug 14, 2026

Vertex to acquire Crinetics after HSR clearance; closing expected early Sept - TradingView

Aug 14, 2026

Crinetics Pharmaceuticals (CRNX) advances Vertex merger after key antitrust milestones - Stock Titan

Aug 14, 2026

Aug 13, 2026

How (CRNX) Movements Inform Risk Allocation Models - Stock Traders Daily

Aug 13, 2026

Crinetics Pharmaceuticals (CRNX): Wellington reports 7.13M-share, 6.76% ownership - Stock Titan

Aug 13, 2026

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 13, 2026

Vertex-Crinetics Pharmaceuticals deal receives clearance in Australia - MLex

Aug 13, 2026

Why Did CRNX, D, BCRX Stocks Surge To 52-Week Highs Today? - Stocktwits

Aug 13, 2026

Aug 11, 2026

Crinetics Pharmaceuticals stock hits all-time high at 84.35 USD By Investing.com - Investing.com Nigeria

Aug 11, 2026

Crinetics Pharmaceuticals stock hits all-time high at 84.35 USD - Investing.com

Aug 11, 2026

Aug 10, 2026

Crinetics Pharmaceuticals (NASDAQ:CRNX) Reaches New 12-Month HighWhat's Next? - MarketBeat

Aug 10, 2026

Weekly Recap: Vertex $10B deal, guidance paused and Q2 loss — Crinetics - TradingView

Aug 10, 2026

Aug 09, 2026

First Trust Advisors LP Raises Stake in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat

Aug 09, 2026

California State Teachers Retirement System Boosts Holdings in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat

Aug 09, 2026